Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Endocannabinoid System Targeted Therapeutics market report explains the definition, types, applications, major countries, and major players of the Endocannabinoid System Targeted Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
By Type:
Oral
Inhalation
Others
By End-User:
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Endocannabinoid System Targeted Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Endocannabinoid System Targeted Therapeutics Outlook to 2028- Original Forecasts
-
2.2 Endocannabinoid System Targeted Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Endocannabinoid System Targeted Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Endocannabinoid System Targeted Therapeutics Market- Recent Developments
-
6.1 Endocannabinoid System Targeted Therapeutics Market News and Developments
-
6.2 Endocannabinoid System Targeted Therapeutics Market Deals Landscape
7 Endocannabinoid System Targeted Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 Endocannabinoid System Targeted Therapeutics Key Raw Materials
-
7.2 Endocannabinoid System Targeted Therapeutics Price Trend of Key Raw Materials
-
7.3 Endocannabinoid System Targeted Therapeutics Key Suppliers of Raw Materials
-
7.4 Endocannabinoid System Targeted Therapeutics Market Concentration Rate of Raw Materials
-
7.5 Endocannabinoid System Targeted Therapeutics Cost Structure Analysis
-
7.5.1 Endocannabinoid System Targeted Therapeutics Raw Materials Analysis
-
7.5.2 Endocannabinoid System Targeted Therapeutics Labor Cost Analysis
-
7.5.3 Endocannabinoid System Targeted Therapeutics Manufacturing Expenses Analysis
8 Global Endocannabinoid System Targeted Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Endocannabinoid System Targeted Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Endocannabinoid System Targeted Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global Endocannabinoid System Targeted Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Inhalation Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Genetic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Pain Disorders Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Endocannabinoid System Targeted Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.2.2 Canada Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.2 UK Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.3 Spain Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.5 France Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.6 Italy Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.8 Finland Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.9 Norway Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.11 Poland Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.12 Russia Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.2 Japan Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.3 India Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.3 Chile Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.6 Peru Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.6.3 Oman Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand Endocannabinoid System Targeted Therapeutics Consumption (2017-2022)
11 Global Endocannabinoid System Targeted Therapeutics Competitive Analysis
-
11.1 GW Pharmaceuticals
-
11.1.1 GW Pharmaceuticals Company Details
-
11.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.1.4 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 MAKScientific
-
11.2.1 MAKScientific Company Details
-
11.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.2.4 MAKScientific Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Corbus Pharmaceuticals
-
11.3.1 Corbus Pharmaceuticals Company Details
-
11.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.3.4 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Tilray
-
11.4.1 Tilray Company Details
-
11.4.2 Tilray Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.4.4 Tilray Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Pure Green
-
11.5.1 Pure Green Company Details
-
11.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.5.4 Pure Green Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Avicanna
-
11.6.1 Avicanna Company Details
-
11.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.6.4 Avicanna Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 GB Sciences
-
11.7.1 GB Sciences Company Details
-
11.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.7.4 GB Sciences Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Botanix Pharmaceuticals
-
11.8.1 Botanix Pharmaceuticals Company Details
-
11.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.8.4 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Therapix Biosciences
-
11.9.1 Therapix Biosciences Company Details
-
11.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.9.4 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Zelira Therapeutics
-
11.10.1 Zelira Therapeutics Company Details
-
11.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
11.10.4 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Endocannabinoid System Targeted Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Inhalation Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Pain Disorders Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Endocannabinoid System Targeted Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Endocannabinoid System Targeted Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Endocannabinoid System Targeted Therapeutics
-
Figure of Endocannabinoid System Targeted Therapeutics Picture
-
Table Global Endocannabinoid System Targeted Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Endocannabinoid System Targeted Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Inhalation Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Table North America Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure United States Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure Germany Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure China Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania Endocannabinoid System Targeted Therapeutics Consumption by Country (2017-2022)
-
Figure Australia Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Endocannabinoid System Targeted Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GW Pharmaceuticals Company Details
-
Table GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table MAKScientific Company Details
-
Table MAKScientific Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table MAKScientific Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table MAKScientific Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Corbus Pharmaceuticals Company Details
-
Table Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Tilray Company Details
-
Table Tilray Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tilray Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Tilray Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Pure Green Company Details
-
Table Pure Green Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pure Green Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Pure Green Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Avicanna Company Details
-
Table Avicanna Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avicanna Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Avicanna Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table GB Sciences Company Details
-
Table GB Sciences Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GB Sciences Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table GB Sciences Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Botanix Pharmaceuticals Company Details
-
Table Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Therapix Biosciences Company Details
-
Table Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Therapix Biosciences Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Table Zelira Therapeutics Company Details
-
Table Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Main Business and Markets Served
-
Table Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhalation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Endocannabinoid System Targeted Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
